S. Van Hemelryck

Determining orthogonal chromatographic systems prior to the development of methods to characterise impurities in drug substances.

D. Massart, M. Daszykowski, F. Questier, 2003, Journal of chromatography. A.

Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants

M. Furey, G. Triana-Baltzer, A. Bhattacharya, 2018, Journal of psychopharmacology.

In vivo Models and Decision Trees for Formulation Development in Early Drug Development: A Review of Current Practices and Recommendations for Biopharmaceutical Development.

P Zane, P Langguth, A Müllertz, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

In Vitro Evaluation of Poly(lactide-co-glycolide) In Situ Forming Gels for Bedaquiline Fumarate Salt and Pharmacokinetics Following Subcutaneous Injection in Rats

R. Holm, P. Langguth, E. Mannaert, 2021, Pharmaceutics.

Preclinical Bioavailability Strategy for Decisions on Clinical Drug Formulation Development: An In Depth Analysis.

M. Brewster, C. Mackie, E. Mannaert, 2018, Molecular pharmaceutics.